Source link : https://www.newshealth.biz/health-news/new-mrna-vaccine-may-shield-against-c-difficile-infections/
A group of researchers from the University of Pennsylvania, Philadelphia, has developed a messenger RNA (mRNA) vaccine, delivered via lipid nanoparticles (LNPs) — the same type as the COVID-19 vaccine produced by Moderna and Pfizer — targeting Clostridioides difficile (formerly Clostridium difficile). According to the authors, the results of their preclinical study, published in Science, […]
Author : News Health
Publish date : 2024-10-29 09:53:09
Copyright for syndicated content belongs to the linked Source.